Goran Ando is a director of EyePoint Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
EyePoint Pharmaceuticals, Inc.
9 Jan 24
4
EyePoint Pharmaceuticals, Inc.
22 Jun 23
4
EyePoint Pharmaceuticals, Inc.
13 Feb 23
4
SELECTA BIOSCIENCES INC
4 Jan 23
4
EyePoint Pharmaceuticals, Inc.
11 Feb 22
4
SELECTA BIOSCIENCES INC
5 Jan 22
4
EyePoint Pharmaceuticals, Inc.
23 Jun 21
4
SELECTA BIOSCIENCES INC
1 Apr 21
4
EyePoint Pharmaceuticals, Inc.
2 Mar 21
4
SELECTA BIOSCIENCES INC
28 Apr 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.4 | 23,598 | 481.40 k | 23,598 |
20 Jun 23 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.5 | 13,500 | 47.25 k | 13,500 |
20 Jun 23 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.26 | 27,100 | 88.35 k | 27,100 |
9 Feb 23 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,250 | 0.00 | 8,150 |
9 Feb 23 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,250 | 0.00 | 0 |